Stock Screener App

無料 -

インストール

2.05

5.09% -0.11

Innate Pharma Adr (IPHA)

概要ニュース株価時系列ディスカッション予測

Innate Pharma Adr (IPHA) 最新ニュース

Nebius Group N.V (NASDAQ: NBIS)’s Upward Trend Continues - Stocks Register

Earnings call: Innate Pharma Q3 2024 results highlight oncology pipeline - Investing.com

Earnings call: Innate Pharma focuses on advancing cancer therapies - Investing.com

Earnings call: Innate Pharma focuses on advancing cancer therapies By Investing.com - Investing.com UK

Earnings call: Innate Pharma reports progress in drug development - Investing.com India

Earnings call: Innate Pharma reports progress in oncology pipeline - Investing.com

Innate Pharma S.A. ADR (IPHA-Q) QuotePress Release - The Globe and Mail

Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update - The Globe and Mail

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update - The Globe and Mail

Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag - Yahoo Movies UK

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting - Investing.com India

All You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy - Yahoo Finance

symbol__ Stock Quote Price and Forecast - CNN

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins - Equities News

IPHA stock surges on upcoming presentation for AstraZeneca-partnered asset - Seeking Alpha

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger - Yahoo Finance

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く